potassium acetate

Generic: potassium acetate

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium acetate
Generic Name potassium acetate
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

potassium acetate 3.93 g/20mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 65219-510
Product ID 65219-510_67c83f58-73cd-47d2-8dbc-e0fd8331c6e7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217515
Listing Expiration 2026-12-31
Marketing Start 2024-11-27

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65219510
Hyphenated Format 65219-510

Supplemental Identifiers

RxCUI
1871155
UPC
0365219510024
UNII
M911911U02

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium acetate (source: ndc)
Generic Name potassium acetate (source: ndc)
Application Number ANDA217515 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 3.93 g/20mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-510-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-510-02)
source: ndc

Packages (1)

Ingredients (1)

potassium acetate (3.93 g/20mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "67c83f58-73cd-47d2-8dbc-e0fd8331c6e7", "openfda": {"upc": ["0365219510024"], "unii": ["M911911U02"], "rxcui": ["1871155"], "spl_set_id": ["bf4dc488-d6f3-41f8-ac8d-37b27f25b8db"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (65219-510-20)  / 20 mL in 1 VIAL, SINGLE-DOSE (65219-510-02)", "package_ndc": "65219-510-20", "marketing_start_date": "20241127"}], "brand_name": "Potassium Acetate", "product_id": "65219-510_67c83f58-73cd-47d2-8dbc-e0fd8331c6e7", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]"], "product_ndc": "65219-510", "generic_name": "POTASSIUM ACETATE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Acetate", "active_ingredients": [{"name": "POTASSIUM ACETATE", "strength": "3.93 g/20mL"}], "application_number": "ANDA217515", "marketing_category": "ANDA", "marketing_start_date": "20241127", "listing_expiration_date": "20261231"}